Toulouse University Hospital
Clinical Trials
747
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (528 trials with phase data)• Click on a phase to view related trials
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
- Conditions
- Endometriosis
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 20
- Registration Number
- NCT07053982
- Locations
- 🇫🇷
Toulouse, Rangueil Hospital, Toulouse, France
Cognitive Remediation Method Using Rhythmic, Vocal and Corporal Musical Learning for Schizophrenia
- Conditions
- Schizophrenia Disorders
- First Posted Date
- 2025-07-08
- Last Posted Date
- 2025-07-08
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 120
- Registration Number
- NCT07055204
- Locations
- 🇫🇷
CH de la Côte Basque, Bayonne, France
🇫🇷CH Le Vinatier, Bron, France
🇫🇷Assistance Publique Hôpitaux de Marseille, Marseille, France
ICOPE INTENSE-K Pilot Study
- Conditions
- Ageing
- First Posted Date
- 2025-07-03
- Last Posted Date
- 2025-07-03
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 40
- Registration Number
- NCT07048860
- Locations
- 🇫🇷
Cité de la santé - Hopital La Grave, Toulouse, France
Pilot Study to Establish a Repertoire of Megakaryocyte Markers, Quantifiable by Spectral Flow Cytometry, in Bone Marrow and Circulating in Patients Undergoing Cardiac Surgery for Bypass Grafting
- Conditions
- Cardiac Surgery for Bypass Grafting
- Interventions
- Biological: Blood and bone marrow sampling
- First Posted Date
- 2025-06-18
- Last Posted Date
- 2025-06-18
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 20
- Registration Number
- NCT07026851
- Locations
- 🇫🇷
Toulouse University Hospital, Toulouse, France
Qualitative Study on the Experiences of Mothers 6 to 12 Months After Their Participation in the Mother-baby Groups of the HUGS Study
- Conditions
- Postnatal DepressionPostpartum Depression (PPD)
- First Posted Date
- 2025-06-12
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- University Hospital, Toulouse
- Target Recruit Count
- 16
- Registration Number
- NCT07017621
- Locations
- 🇫🇷
Paule De Viguier Hospital, Toulouse, Occitanie, France
🇫🇷Bordeaux Public Hospital, Bordeaux, France
🇫🇷Joseph Ducuing, Toulouse, France
- Prev
- 1
- 2
- 3
- 4
- 5
- 149
- Next
News
Lixisenatide Shows Promise in Slowing Parkinson's Disease Progression in Phase 2 Trial
A Phase 2 trial of Sanofi's lixisenatide demonstrated the GLP-1 agonist's potential to halt motor symptom progression in Parkinson's disease patients over 12 months.